• Je něco špatně v tomto záznamu ?

Prevalence and clinical characteristics of patients with true resistant hypertension in central and Eastern Europe: data from the BP-CARE study

G. Brambilla, M. Bombelli, G. Seravalle, R. Cifkova, S. Laurent, K. Narkiewicz, R. Facchetti, J. Redon, G. Mancia, G. Grassi,

. 2013 ; 31 (10) : 2018-24.

Jazyk angličtina Země Anglie, Velká Británie

Typ dokumentu časopisecké články, multicentrická studie, práce podpořená grantem

Perzistentní odkaz   https://www.medvik.cz/link/bmc14064113

OBJECTIVE: Scanty information is available on the clinical characteristics of resistant hypertension in Central and East European countries. The Blood Pressure (BP) control rate and CArdiovascular Risk profilE (BP-CARE) study allowed us to assess the prevalence and the main clinical features of resistant hypertension in this population. DESIGN AND METHOD: The study was carried out in 1312 treated hypertensive patients living in nine Central and East European countries. RESULTS: Four hundred and twenty-three patients had apparent resistant hypertension, of whom 168 had pseudo-resistant hypertension (noncompliant/white-coat) and 255 were true treatment-resistant hypertension patients (TRH). Clinical BP values in TRH amounted to 157.4±16.9/91.8±10.0 mmHg despite the daily use of 3.6±0.7 drugs. Their 24-h BP values were 149.5±16.5/97.5±9.8 mmHg. Compared to controlled hypertensive patients (n=368) and uncontrolled nonresistant hypertensive patients (n=521), TRH were older with a greater prevalence of women. They showed a higher rate of previous cardiovascular events and a very high cardiovascular risk profile. Estimated glomerular filtration rate was significantly lower in TRH as compared to controlled hypertensive patients and uncontrolled nonresistant hypertensive patients. Overall, target organ damage was more frequently detected in TRH than in controlled hypertensive patients and uncontrolled nonresistant hypertensive patients. The factor most frequently associated with TRH was severity of hypertension followed by age, total cholesterol, BMI and history of heart failure. CONCLUSIONS: The present study provides evidence that the prevalence of TRH in Central and East European countries is similar to that found in Western Europe and USA. It also shows the very high cardiovascular risk of TRH and the elevated association of this condition with obesity, renal failure, organ damage and history of cardiovascular events.

Citace poskytuje Crossref.org

000      
00000naa a2200000 a 4500
001      
bmc14064113
003      
CZ-PrNML
005      
20140708123430.0
007      
ta
008      
140704s2013 enk f 000 0|eng||
009      
AR
024    7_
$a 10.1097/HJH.0b013e328363823f $2 doi
035    __
$a (PubMed)23838657
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a enk
100    1_
$a Brambilla, Gianmaria $u aClinica Medica, Università Milano-Bicocca, Ospedale San Gerardo dei Tintori, Monza bIstituto Auxologico Italiano, Ospedale San Luca, Milan, Italy cCenter for Cardiovascular Prevention, Thomayer Hospital and Department of Preventive Cardiology, Institute of Clinical and Experimental Medicine, Prague, Czech Republic dPharmacology Department and INSERM U970 Hopital Europeen Georges Pompidou, Assistance-Publique Hopitaux de Paris, Paris-Derscartes University, France eDepartment of Hypertension and Diabetology, Medical University of Gdansk, Gdansk, Poland fInternal Medicine, Hospital Clinico, University of Valencia, Valencia, Spain gIRCCS MultiMedica, Sesto San Giovanni, Milan, Italy.
245    10
$a Prevalence and clinical characteristics of patients with true resistant hypertension in central and Eastern Europe: data from the BP-CARE study / $c G. Brambilla, M. Bombelli, G. Seravalle, R. Cifkova, S. Laurent, K. Narkiewicz, R. Facchetti, J. Redon, G. Mancia, G. Grassi,
520    9_
$a OBJECTIVE: Scanty information is available on the clinical characteristics of resistant hypertension in Central and East European countries. The Blood Pressure (BP) control rate and CArdiovascular Risk profilE (BP-CARE) study allowed us to assess the prevalence and the main clinical features of resistant hypertension in this population. DESIGN AND METHOD: The study was carried out in 1312 treated hypertensive patients living in nine Central and East European countries. RESULTS: Four hundred and twenty-three patients had apparent resistant hypertension, of whom 168 had pseudo-resistant hypertension (noncompliant/white-coat) and 255 were true treatment-resistant hypertension patients (TRH). Clinical BP values in TRH amounted to 157.4±16.9/91.8±10.0 mmHg despite the daily use of 3.6±0.7 drugs. Their 24-h BP values were 149.5±16.5/97.5±9.8 mmHg. Compared to controlled hypertensive patients (n=368) and uncontrolled nonresistant hypertensive patients (n=521), TRH were older with a greater prevalence of women. They showed a higher rate of previous cardiovascular events and a very high cardiovascular risk profile. Estimated glomerular filtration rate was significantly lower in TRH as compared to controlled hypertensive patients and uncontrolled nonresistant hypertensive patients. Overall, target organ damage was more frequently detected in TRH than in controlled hypertensive patients and uncontrolled nonresistant hypertensive patients. The factor most frequently associated with TRH was severity of hypertension followed by age, total cholesterol, BMI and history of heart failure. CONCLUSIONS: The present study provides evidence that the prevalence of TRH in Central and East European countries is similar to that found in Western Europe and USA. It also shows the very high cardiovascular risk of TRH and the elevated association of this condition with obesity, renal failure, organ damage and history of cardiovascular events.
650    _2
$a dospělí $7 D000328
650    _2
$a senioři $7 D000368
650    _2
$a antihypertenziva $x terapeutické užití $7 D000959
650    _2
$a krevní tlak $7 D001794
650    _2
$a měření krevního tlaku $7 D001795
650    _2
$a index tělesné hmotnosti $7 D015992
650    _2
$a kardiovaskulární nemoci $x komplikace $x farmakoterapie $x epidemiologie $7 D002318
650    _2
$a průřezové studie $7 D003430
650    12
$a léková rezistence $7 D004351
650    _2
$a ženské pohlaví $7 D005260
650    _2
$a hodnoty glomerulární filtrace $7 D005919
650    _2
$a lidé $7 D006801
650    _2
$a hypertenze $x farmakoterapie $x epidemiologie $7 D006973
650    _2
$a mužské pohlaví $7 D008297
650    _2
$a lidé středního věku $7 D008875
650    _2
$a obezita $x komplikace $7 D009765
650    _2
$a prevalence $7 D015995
650    _2
$a renální insuficience $x komplikace $7 D051437
650    _2
$a rizikové faktory $7 D012307
650    _2
$a výsledek terapie $7 D016896
650    _2
$a syndrom bílého pláště $x diagnóza $x epidemiologie $7 D059466
651    _2
$a východní Evropa $x epidemiologie $7 D005061
655    _2
$a časopisecké články $7 D016428
655    _2
$a multicentrická studie $7 D016448
655    _2
$a práce podpořená grantem $7 D013485
700    1_
$a Bombelli, Michele
700    1_
$a Seravalle, Gino
700    1_
$a Cifkova, Renata
700    1_
$a Laurent, Stephane
700    1_
$a Narkiewicz, Krzysztof
700    1_
$a Facchetti, Rita
700    1_
$a Redon, Josep
700    1_
$a Mancia, Giuseppe
700    1_
$a Grassi, Guido
773    0_
$w MED00002723 $t Journal of hypertension $x 1473-5598 $g Roč. 31, č. 10 (2013), s. 2018-24
856    41
$u https://pubmed.ncbi.nlm.nih.gov/23838657 $y Pubmed
910    __
$a ABA008 $b sig $c sign $y a $z 0
990    __
$a 20140704 $b ABA008
991    __
$a 20140708123720 $b ABA008
999    __
$a ok $b bmc $g 1031597 $s 862845
BAS    __
$a 3
BAS    __
$a PreBMC
BMC    __
$a 2013 $b 31 $c 10 $d 2018-24 $i 1473-5598 $m Journal of hypertension $n J Hypertens $x MED00002723
LZP    __
$a Pubmed-20140704

Najít záznam

Citační ukazatele

Pouze přihlášení uživatelé

Možnosti archivace

Nahrávání dat ...